What factors influence the sample size in a clinical trial?

• A. The severity of the disease, cost of the study, and duration.
• B. The disease to be investigated, the study objective, and the study endpoints.
• C. The pharmacokinetics of the drug only.
• D. The number of investigators involved.

Answer: (B)

Sample size is driven by what the trial aims to show and how outcomes will be measured. The disease to be investigated sets the baseline risk and potential variability in the population, affecting how many participants are needed to observe a meaningful result. The study objective defines the hypothesis and the type of comparison you want to make (for example, showing superiority, noninferiority, or equivalence), which in turn determines the smallest clinically important difference you need to detect and the power you want to achieve. The study endpoints shape the data type and precision—continuous, binary, or time-to-event outcomes each require different variance assumptions and effect sizes, influencing the number of participants needed to achieve adequate statistical power. Because of these interconnected factors, the planned sample size hinges on the disease context, the trial’s objective, and the chosen endpoints. Practical feasibility factors like cost or duration can affect recruitment but do not determine the statistical size of the trial, and pharmacokinetics alone or the number of investigators does not set the sample size.